a qualitative study of provider thoughts on implementing pre-exposure prophylaxis (prep) in clinical settings to prevent hiv infection定性研究提供者暴露前预防思想实现(预科)预防艾滋病毒感染在临床的设置.pdfVIP

下载本文档

1
0
约7.4万字
约 8页
2017-09-07 发布于上海
举报
版权申诉

a qualitative study of provider thoughts on implementing pre-exposure prophylaxis (prep) in clinical settings to prevent hiv infection定性研究提供者暴露前预防思想实现(预科)预防艾滋病毒感染在临床的设置.pdf

1、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

a qualitative study of provider thoughts on implementing pre-exposure prophylaxis (prep) in clinical settings to prevent hiv infection定性研究提供者暴露前预防思想实现(预科)预防艾滋病毒感染在临床的设置

A Qualitative Study of Provider Thoughts on Implementing Pre-Exposure Prophylaxis (PrEP) in Clinical Settings to Prevent HIV Infection 1 1 1 2 1 Emily A. Arnold *, Patrick Hazelton , Tim Lane , Katerina A. Christopoulos , Gabriel R. Galindo , Wayne T. Steward1, Stephen F. Morin1 1 Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, United States of America, 2 HIV/AIDS Division, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America Abstract Background: A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabrine (TDF- FTC) can reduce HIV acquisition among men who have sex with men (MSM) and transgender (TG) women by 44%, and up to 90% if taken daily. We explored how medical and service providers understand research results and plan to develop clinical protocols to prescribe, support and monitor adherence for patients on PrEP in the United States. Methods: Using referrals from our community collaborators and snowball sampling, we recruited 22 healthcare providers in San Francisco, Oakland, and Los Angeles for in-depth interviews from May-December 2011. The providers included primary care physicians seeing high numbers of MSM and TG women, HIV specialists, community health clinic providers, and public health officials. We analyzed interviews thematically to produce recommendations for setting policy around implementing PrEP. Interview topics included: assessing clinician impressions of PrEP and CDC guidance, considerations of cost, office capacity, dosing schedules, and following patients over time. Results: Little or no demand for PrEP from patients was repo